tm logo

Monitor this mark

View On USPTO

VIMIZIM
Live/Registered
REGISTERED AND RENEWED

on 27 Jul 2024

Last Applicant/ Owned by

Biomarin Pharmaceutical, Inc.

105 Digital Drive

Novato

CA

94949

Serial Number

85599526 filed on 17th Apr 2012

Registration Number

4538367 registered on 27th May 2014

in the Principal Register

Correspondent Address

Richard M. LaBarge

Richard M. LaBarge Marshall, Gerstein & Borun LLP

CHICAGO, IL 60606

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

VIMIZIM

pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for use in enzyme therapy

Classification Information

Class [005]
Pharmaceutical Products

pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for use in enzyme therapy

First Use Date in General

18th Feb 2014

First Use Date in Commerce

18th Feb 2014

Mark Details

Serial Number

No 85599526

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 32215/61774

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
27th Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27th Jul 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
27th Jul 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27th Jul 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th May 2024TEAS SECTION 8 & 9 RECEIVED
27th May 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01st Apr 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01st Apr 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01st Apr 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05th Feb 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED